Development and Validation of a Digital-Artificial Intelligent (AI) enabled Assay to predict early-stage breast cancer recurrence. (November 2022) - Fernandez, G.; Prastawa, M.; Scott, R.; Marami, B.; Shpalensky, N.; Madduri, A.; Cascetta, K.; Sawyer, M.; Chan, M.; Koll, G.; Malinowski, D.; De Angel, R.; et al.